Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate if the medication Gabapentin, which is not approved
for the treatment of alcohol withdrawal, is effective in the treatment of alcohol withdrawal
syndrome compared to treatment with Lorazepam.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)